|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 471/20 | |
| A61K 31/35 | |||
| A61P 9/00 |
| (11) | Number of the document | 1885724 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06763351.1 |
| Date of filing the European patent application | 2006-05-30 | |
| (97) | Date of publication of the European application | 2008-02-13 |
| (45) | Date of publication and mention of the grant of the patent | 2010-06-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2006/062696 |
| Date | 2006-05-30 |
| (87) | Number | WO 2006/128853 |
| Date | 2006-12-07 |
| (30) | Number | Date | Country code |
| 923052005 | 2005-05-31 | CH |
| (72) |
HEROLD, Peter, CH
MAH, Robert, CH
TSCHINKE, Vincenzo, CH
STOJANOVIC, Aleksandar, CH
MARTI, Christiane, CH
JOTTERAND, Nathalie, CH
SCHUMACHER, Christoph, CH
QUIRMBACH, Michael, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | HETEROCYCLIC SPIRO-COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS |
| HETEROCYCLIC SPIRO-COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS |